title: Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.
authors.affiliation: Genetic Services, King Edward Memorial Hospital, Subiaco, Western Australia.
authors.forename: A
authors.initials: A
authors.lastname: Hockey
authors.forename: C
authors.initials: C
authors.lastname: Bower
authors.forename: J
authors.initials: J
authors.lastname: Goldblatt
authors.forename: S
authors.initials: S
authors.lastname: Knowles
mesh_terms: D000015:Abnormalities, Multiple / Q000139:chemically induced* / Q000235:genetics*; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D004200:Diseases in Twins; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D010375:Pedigree; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D014429:Twins, Dizygotic; D014635:Valproic Acid / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid